Tamtam Try Tamtam free
Luzerner Kantonsspital logo

Luzerner Kantonsspital account plan

Compassionate patient-centered hospital care

At a glance

Luzerner Kantonsspital (LUKS Gruppe) is a cantonal hospital group in Central Switzerland with 8,628 employees and CHF 1.341 bn revenue in 2025.

LUKS Gruppe, whose legal entity Luzerner Kantonsspital AG is 100% owned by the Canton of Lucerne, provides basic to highly specialised care for the Canton of Lucerne and Central Switzerland. It runs hospitals in Luzern (a university teaching and research hospital), Sursee and Wolhusen, and holds 60% of Spital Nidwalden in Stans. In 2025 revenue was CHF 1.341 bn (+7.2%) and the annual result CHF 42.2 m, after CHF -24.6 m in 2024, with 8,628 employees, 51,572 inpatients and 970,542 outpatient contacts. Florian Aschbrenner has been CEO since 01.04.2025 and Dr. med. Martin Nufer chairs the board.

Business units

Strategic priorities

Reaching the financial targets
The group targets an EBITDA margin of at least 10% and an equity ratio of at least 50%; in 2025 the EBITDA margin was 8.6% and the equity ratio 45.1%.
Strategy process and transformation
A comprehensive strategy process started in early summer 2025 and runs through 2026, covering cross-site organisation, the service portfolio and financial steering.
Shift to outpatient care
About 40% of medical revenue comes from outpatient care and the share is rising; the group is expanding outpatient processes such as the ambulatory surgery centre in Sursee.
Integrating Kantonsspital Obwalden
Kantonsspital Obwalden joins the group in 2028/2029, with harmonisation of clinical and operational processes as the focus.
Digital and clinical innovation
Standardise the Epic clinical information system (LUKiS), extend the Virtual Care Unit, push robotics in surgery and diagnostics, and pursue the net-zero target and lean processes.

Investments and deals

Kinderspital and Frauenklinik Luzern
Opened on 16 September 2026 with moves in October 2026; forecast investment is about CHF 202 m for the Kinderspital and about CHF 94 m for the Frauenklinik, including equipment.
New hospital in Wolhusen
Shell completed in September 2025, interior fit-out under way and opening scheduled for 2028.
Review of large building projects
The board is reassessing the Sursee new build and the Ambulantes Zentrum and Stationäres Zentrum in Luzern for size, focus and investment volume.
Capital spending and financing
TCHF 158,325 was added to assets under construction in 2025; long-term debt of CHF 386 m includes a 2.10% CHF 150 m Green Bond due 2034.
Divestments
Sold Luzerner Höhenklinik Montana (01.01.2026), the 40% stake in Medbase Zentralschweiz AG and the stake in Bluespace Ventures AG.

Challenges and risks

Infrastructure financing burden
Leaders say the positive 2025 result should not hide the financial challenges from the planned infrastructure investments, which raise borrowing.
Outpatient tariffs
Delivering outpatient care in structures built mainly for inpatients causes efficiency losses that current tariffs hardly cover.
Skilled staff shortage and demographics
Population growth and ageing, the skilled staff shortage and cost pressure are named as structural pressures.
Leadership turnover and internal mood
The CMO, CIO and two COOs left during 2025, and the CEO acknowledged in early 2026 that internal communication about the transformation had not been enough.

What leadership says

“Die bisherige Kommunikation reicht offenbar nicht aus. Es ist enorm wichtig, die Mitarbeitenden noch besser abzuholen”

Florian Aschbrenner, CEO · Communication so far is apparently not enough; staff must be brought along better. Luzerner Zeitung interview reported by Medinside, 2 February 2026

“Die eingeleiteten Massnahmen entfalten Wirkung. Gleichzeitig bleiben die strukturellen Rahmenbedingungen anspruchsvoll”

Florian Aschbrenner, CEO · On Spital Nidwalden: the measures are taking effect while conditions remain demanding. 2025 results press release, 30 April 2026

“Das Ergebnis 2025 zeigt, dass wir auf dem richtigen Weg sind”

Dr. med. Martin Nufer, Chair of the Board · The 2025 result shows we are on the right path. 2025 results press release, 30 April 2026

“Ein Gebäude allein macht noch kein Spital. Entscheidend sind die Menschen, die darin arbeiten”

Florian Aschbrenner, CEO · A building alone does not make a hospital. Kinderspital and Frauenklinik opening release, 16 September 2026

Where a supplier can help

Outpatient process efficiency
Tied to the outpatient shift: scheduling, patient flow and day-surgery solutions address the efficiency losses of running outpatient care in inpatient structures.
Commissioning new buildings
Tied to the Kinderspital/Frauenklinik opening and the Wolhusen build: medical equipment, logistics and facilities services fit the commissioning and transfer of operations.
Epic and virtual care
Tied to the LUKiS standardisation and Virtual Care Unit priorities: integration, analytics and remote monitoring offers support the digital roadmap and the Obwalden integration.
Change management and staff retention
Tied to the transformation and the skilled staff shortage: internal communication, workforce and retention offers match the CEO's stated need to bring staff along.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Luzerner Kantonsspital?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Luzerner Kantonsspital

What is Luzerner Kantonsspital?

LUKS Gruppe is a hospital group owned by the Canton of Lucerne, running hospitals in Luzern, Sursee and Wolhusen and a 60% stake in Spital Nidwalden.

What is LUKS Gruppe's revenue?

Revenue was CHF 1.341 bn in 2025, up 7.2%, with an annual result of CHF 42.2 m.

How many employees does LUKS have?

8,628 employees in 2025, including 960 people in apprenticeships or training.

Who leads Luzerner Kantonsspital?

Florian Aschbrenner has been CEO since 01.04.2025, and Dr. med. Martin Nufer chairs the board.

What is LUKS's strategy?

A strategy process running through 2026 aims at an EBITDA margin of at least 10%, more outpatient care, digital and robotic innovation and the integration of Kantonsspital Obwalden.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)